Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Diana Medgyesy

Concepts (51)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antimetabolites, Antineoplastic
4
2003
108
0.150
Why?
Fluorouracil
5
2013
231
0.130
Why?
Tegafur
5
2003
12
0.090
Why?
Colorectal Neoplasms
4
2000
874
0.080
Why?
Deoxycytidine
5
2013
219
0.080
Why?
Oxonic Acid
4
2003
13
0.070
Why?
Camptothecin
2
2000
139
0.070
Why?
Uracil
4
2000
37
0.070
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2013
1998
0.070
Why?
Capecitabine
5
2013
56
0.060
Why?
Pyridines
4
2003
610
0.050
Why?
Breast Neoplasms
2
2013
2418
0.050
Why?
Prodrugs
2
1999
54
0.040
Why?
Gastrointestinal Neoplasms
1
2003
74
0.040
Why?
Folic Acid Antagonists
1
1999
8
0.040
Why?
Leucovorin
4
2000
98
0.040
Why?
Oxidoreductases
1
1999
91
0.040
Why?
Antineoplastic Agents
2
1999
2219
0.030
Why?
Enzyme Inhibitors
1
1999
823
0.030
Why?
Drug Combinations
3
2003
400
0.030
Why?
Dose-Response Relationship, Drug
2
2013
2022
0.030
Why?
Stomatitis
1
2013
15
0.020
Why?
Administration, Oral
3
2000
872
0.020
Why?
Bevacizumab
1
2013
169
0.020
Why?
Phenylurea Compounds
1
2013
122
0.020
Why?
Niacinamide
1
2013
103
0.020
Why?
Skin Diseases
1
2013
144
0.020
Why?
Disease-Free Survival
1
2013
778
0.020
Why?
Drug Administration Schedule
1
2013
790
0.020
Why?
Fatigue
1
2013
363
0.020
Why?
Kaplan-Meier Estimate
1
2013
970
0.020
Why?
Double-Blind Method
1
2013
2070
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2013
992
0.020
Why?
Treatment Outcome
3
2013
11821
0.010
Why?
Disease Progression
1
2013
2867
0.010
Why?
Area Under Curve
1
2003
335
0.010
Why?
Organoplatinum Compounds
1
2000
65
0.010
Why?
Clinical Trials, Phase II as Topic
1
2000
74
0.010
Why?
Clinical Trials, Phase III as Topic
1
2000
116
0.010
Why?
Dihydrouracil Dehydrogenase (NADP)
1
1999
5
0.010
Why?
Aged
2
2013
26432
0.010
Why?
Humans
7
2013
146342
0.010
Why?
Infusions, Intravenous
1
1998
432
0.010
Why?
Middle Aged
2
2013
36619
0.010
Why?
Adult
2
2013
41087
0.010
Why?
Neoplasm Metastasis
1
1998
693
0.010
Why?
Randomized Controlled Trials as Topic
1
2000
1763
0.010
Why?
Female
3
2013
79499
0.010
Why?
Time Factors
1
2003
7109
0.010
Why?
Animals
2
1999
38107
0.000
Why?
Male
2
2003
73396
0.000
Why?
Medgyesy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)